# Sunrise Realty Trust, Inc.: financial statements, quarterly

SUNS · Nasdaq · CIK 2012706 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/suns.md) · [Financials](/companies/suns/financials.md) · [Filings](/companies/suns/filings.md) · [Insiders](/companies/suns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/suns/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,026](/filings/0002012706-25-000020.md) | [1,980](/filings/0002012706-25-000041.md) | [3,178](/filings/0001628280-25-051845.md) | [3,445 d](/filings/0001628280-26-017017.md) | [4,622](/filings/0001628280-26-034794.md) | [5,669](/filings/0001628280-26-053845.md) | [6,056](/filings/0001628280-25-051845.md) | [5,223 d](/filings/0001628280-26-017017.md) | [7,305](/filings/0001628280-26-034794.md) | [5,819](/filings/0001628280-26-053845.md) |
| Income tax | $k | [0.0](/filings/0002012706-25-000020.md) | [0.0](/filings/0002012706-25-000041.md) | [0.0](/filings/0001628280-25-051845.md) | [0.0 d](/filings/0001628280-26-017017.md) | [0.0](/filings/0001628280-26-034794.md) | [0.0](/filings/0001628280-26-053845.md) | [0.0](/filings/0001628280-25-051845.md) | [0.0 d](/filings/0001628280-26-017017.md) | [0.0](/filings/0001628280-26-034794.md) | [0.0](/filings/0001628280-26-053845.md) |
| Net income | $k | [1,762](/filings/0002012706-25-000020.md) | [1,514](/filings/0002012706-25-000041.md) | [1,738](/filings/0001628280-25-051845.md) | [1,854 d](/filings/0001628280-26-017017.md) | [3,099](/filings/0001628280-26-034794.md) | [3,358](/filings/0001628280-26-053845.md) | [4,055](/filings/0001628280-25-051845.md) | [1,630 d](/filings/0001628280-26-017017.md) | [4,253](/filings/0001628280-26-034794.md) | [3,076](/filings/0001628280-26-053845.md) |
| Diluted EPS | $ per share | [0.26](/filings/0002012706-25-000020.md) | [0.22](/filings/0002012706-25-000041.md) | [0.25](/filings/0001628280-25-051845.md) | not reported | [0.27](/filings/0001628280-26-034794.md) | [0.25](/filings/0001628280-26-053845.md) | [0.30](/filings/0001628280-25-051845.md) | not reported | [0.32](/filings/0001628280-26-034794.md) | [0.23](/filings/0001628280-26-053845.md) |
| Basic EPS | $ per share | [0.26](/filings/0002012706-25-000020.md) | [0.22](/filings/0002012706-25-000041.md) | [0.26](/filings/0001628280-25-051845.md) | not reported | [0.27](/filings/0001628280-26-034794.md) | [0.25](/filings/0001628280-26-053845.md) | [0.30](/filings/0001628280-25-051845.md) | not reported | [0.32](/filings/0001628280-26-034794.md) | [0.23](/filings/0001628280-26-053845.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [31.2](/filings/0002012706-25-000004.md) | not reported | [11.3](/filings/0002012706-24-000009.md) | [70.2](/filings/0002012706-24-000015.md) | [185](/filings/0001628280-26-017017.md) | [1.6](/filings/0002012706-25-000020.md) | [5.6](/filings/0002012706-25-000041.md) | [5.5](/filings/0001628280-25-051845.md) | [6.4](/filings/0001628280-26-053845.md) | [5.7](/filings/0001628280-26-034794.md) | [5.6](/filings/0001628280-26-053845.md) |
| Total assets | $m | not reported | [31.2](/filings/0002012706-25-000004.md) | not reported | [49.5](/filings/0002012706-24-000009.md) | [168](/filings/0002012706-24-000015.md) | [318](/filings/0001628280-26-017017.md) | [234](/filings/0002012706-25-000020.md) | [256](/filings/0002012706-25-000041.md) | [259](/filings/0001628280-25-051845.md) | [310](/filings/0001628280-26-053845.md) | [330](/filings/0001628280-26-034794.md) | [331](/filings/0001628280-26-053845.md) |
| Total liabilities | $m | not reported | [0.0](/filings/0002012706-25-000004.md) | not reported | [0.6](/filings/0002012706-24-000009.md) | [55.7](/filings/0002012706-24-000015.md) | [203](/filings/0001628280-26-017017.md) | [49.6](/filings/0002012706-25-000020.md) | [72.2](/filings/0002012706-25-000041.md) | [74.2](/filings/0001628280-25-051845.md) | [128](/filings/0001628280-26-053845.md) | [148](/filings/0001628280-26-034794.md) | [149](/filings/0001628280-26-053845.md) |
| Shareholders' equity | $m | [21.0](/filings/0002012706-24-000015.md) | [31.2](/filings/0001628280-26-017017.md) | [47.4](/filings/0002012706-25-000041.md) | [48.9](/filings/0001628280-25-051845.md) | [112](/filings/0001628280-25-051845.md) | [114](/filings/0001628280-26-053845.md) | [185](/filings/0001628280-26-053845.md) | [184](/filings/0001628280-26-053845.md) | [185](/filings/0001628280-25-051845.md) | [182](/filings/0001628280-26-053845.md) | [183](/filings/0001628280-26-053845.md) | [182](/filings/0001628280-26-053845.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,118](/filings/0002012706-25-000020.md) | [2,081 d](/filings/0002012706-25-000041.md) | [(513) d](/filings/0001628280-25-051845.md) | [(1,045) d](/filings/0001628280-26-017017.md) | [(915)](/filings/0001628280-26-034794.md) | [(323) d](/filings/0001628280-26-053845.md) | [(656) d](/filings/0001628280-25-051845.md) | [(1,537) d](/filings/0001628280-26-017017.md) | [1,165](/filings/0001628280-26-034794.md) | [371 d](/filings/0001628280-26-053845.md) |
| Dividends paid | $k | [0.0](/filings/0002012706-25-000020.md) | [0.0 d](/filings/0002012706-25-000041.md) | [0.0 d](/filings/0001628280-25-051845.md) | [1,454 d](/filings/0001628280-26-017017.md) | [2,942](/filings/0001628280-26-034794.md) | [4,026 d](/filings/0001628280-26-053845.md) | [4,026 d](/filings/0001628280-25-051845.md) | [4,026 d](/filings/0001628280-26-017017.md) | [4,026](/filings/0001628280-26-034794.md) | [4,056 d](/filings/0001628280-26-053845.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.9](/filings/0002012706-25-000020.md) | [6.9](/filings/0002012706-25-000041.md) | [6.8](/filings/0001628280-25-051845.md) | [11.2](/filings/0001628280-26-034794.md) | [13.3](/filings/0001628280-26-053845.md) | [13.3](/filings/0001628280-25-051845.md) | [13.3](/filings/0001628280-26-034794.md) | [13.3](/filings/0001628280-26-053845.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,515,851 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053845.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.